ArticleDiabetes, obesity & metabolism2023

Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics.

Philip D Home et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.